GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Aker BioMarine ASA (OSL:AKBM) » Definitions » Interest Expense

Aker BioMarine ASA (OSL:AKBM) Interest Expense : kr-343 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Aker BioMarine ASA Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Aker BioMarine ASA's interest expense for the three months ended in Mar. 2024 was kr -65 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was kr-343 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Aker BioMarine ASA's Operating Income for the three months ended in Mar. 2024 was kr -59 Mil. Aker BioMarine ASA's Interest Expense for the three months ended in Mar. 2024 was kr -65 Mil. Aker BioMarine ASA did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Aker BioMarine ASA Interest Expense Historical Data

The historical data trend for Aker BioMarine ASA's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aker BioMarine ASA Interest Expense Chart

Aker BioMarine ASA Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -205.61 -163.15 -123.04 -200.57 -352.35

Aker BioMarine ASA Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -80.05 -110.12 -87.94 -80.18 -64.73

Aker BioMarine ASA Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-343 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aker BioMarine ASA  (OSL:AKBM) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Aker BioMarine ASA's Interest Expense for the three months ended in Mar. 2024 was kr-65 Mil. Its Operating Income for the three months ended in Mar. 2024 was kr-59 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was kr3,618 Mil.

Aker BioMarine ASA's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Aker BioMarine ASA did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Aker BioMarine ASA (OSL:AKBM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Aker BioMarine ASA (OSL:AKBM) » Definitions » Interest Expense
Comparable Companies
OSL:KING XSWX:NESN KHC GIS XPAR:BN SHSE:603288 NSE:NESTLEIND SZSE:300999 SHSE:600887 TSE:2802 LSE:ABF BIMBOA K HRL MKC SGX:F34 SAU:2280 DUB:KRZ BOM:500825 XAMS:JDEP
Traded in Other Exchanges
1PG:Germany
Address
Oksenoyveien 10, P.O. Box 496, Lysaker, NOR, NO-1327
Website
https://www.akerbiomarine.com
Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution worldwide from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include 1) The Ingredients segment involves offshore harvesting and production, logistical operations, and onshore manufacturing and sales of krill-derived products. 2) The Brands segment focuses on human consumer goods, with Lang Pharma Nutrition (Lang) and Epion as its two main components. Lang produces and distributes private-label vitamins and supplements to retailers in the U.S. market and Epion is Aker BioMarine's consumer brand company.

Aker BioMarine ASA (OSL:AKBM) Headlines

No Headlines